By admin
CPNP notification: what it is and who files it when you use a contract manufacturer
The CPNP is the European portal through which the Responsible Person notifies a cosmetic product before it is placed on the market, in accordance with Regulation (EC) No 1223/2009. The service is free of charge, and notification does not constitute approval. In contract manufacturing, it is essential to clarify who assumes responsibility and who manages the notification submission process.
When developing a cosmetic product line, formulation, packaging and communication are the most visible activities. Alongside these, launching a product requires documentation and regulatory procedures that should be planned from the initial brief: CPNP notification is one of these essential steps. Understanding its purpose and requirements helps integrate it into the development timeline, avoiding delays before commercialisation.
What is the CPNP portal?
CPNP stands for Cosmetic Products Notification Portal. It is the European Commission’s online system used to notify cosmetic products intended for the European Union market.
The information is accessible to competent authorities for market surveillance purposes and to poison centres for the management of medical emergencies. Once a product has been notified through the CPNP, no additional national notification of the same product is required within the EU.
Notification does not certify the safety or efficacy of a cosmetic product: the portal collects the information submitted and does not represent a system of prior approval.
When must a CPNP notification be submitted?
Notification must be completed before the cosmetic product is placed on the European market, meaning before its first commercial supply.
This obligation also applies to products distributed free of charge as part of a commercial activity.
When the product is placed on the market, the original labelling and, where reasonably legible, a photograph of the corresponding packaging must also be submitted.
For certain cosmetic products containing nanomaterials, an additional notification is required, generally six months in advance, subject to specific exceptions.
What information is required to notify a cosmetic product?
The notification collects the information needed to identify the cosmetic product and provide relevant details to competent authorities and poison centres.
| Information | What it includes |
| Cosmetic product identification | Product category and name allowing specific identification |
| Responsible Person | Name or registered company name and address where the PIF is readily accessible |
| Market | Member State where the product is first placed on the market and country of origin for imported products |
| Contact details | Contact details of a natural person who can be contacted when necessary |
| Specific substances | Required information on nanomaterials and any CMR substances classified as category 1A or 1B |
| Formulation | Formulation information required to enable prompt and appropriate medical treatment |
| Product presentation | Original labelling and a photograph of the packaging, as required by the applicable provisions |
CMR substances are substances classified as carcinogenic, mutagenic or toxic to reproduction. Their inclusion in the notification requirements does not mean they can be used without restrictions: their use is subject to the limitations and possible exemptions established by cosmetic legislation.
The information must describe the actual version of the product, ensuring consistency between its name, formulation and packaging.
Who submits the notification in contract manufacturing and private label production?
The notification obligation lies with the Responsible Person. This entity is not necessarily the laboratory that physically manufactures the product.
The brand may assume this role or, where permitted and in accordance with the applicable procedures, another entity established within the EU may be designated.
The operational submission process may therefore be carried out by authorised personnel or consultants.
Even when starting from an existing formulation, verification is necessary: it should not be assumed that the notification of a product marketed under another brand automatically covers the new product.
To learn more about the available development approaches, read “Private Label or Custom Formulation: How to Choose for Your Cosmetic Line”.
What is the relationship between CPNP notification and the PIF?
The PIF, Product Information File, is the documentation file relating to a cosmetic product. It includes:
- Product description.
- Cosmetic Product Safety Report.
- Manufacturing method and a statement of compliance with Good Manufacturing Practice (GMP).
- Evidence supporting the claimed effects, where justified by the nature of the product or its claims.
The PIF must be kept up to date and made accessible to competent authorities for ten years after the last batch of the cosmetic product has been placed on the market.
The PIF and CPNP notification are separate regulatory obligations: submitting information through the CPNP does not replace the Product Information File or the safety assessment.
Product labelling must be consistent with this documentation. The topic is explored in greater detail in the guide “Cosmetic Labelling: What Information Is Required by Law”.
What mistakes should be avoided when managing CPNP notification?
Before launching a product, it is important to ensure that you have not:
- Started commercial distribution before completing the notification.
- Submitted inconsistent information across the product, labelling and portal.
- Overlooked the information required for specific substances or nanomaterials.
- Failed to define responsibilities for managing subsequent updates.
- Confused the submission of information with the fulfilment of all regulatory compliance obligations.
Whenever the information required under Article 13 changes, it must be updated without delay. Any modification to the formulation also requires an assessment of its implications for product safety, the PIF and labelling.
How should CPNP notification be organised with the manufacturer?
During the initial project brief, four key aspects should be defined: the Responsible Person, preparation of documentation, submission of the notification and management of subsequent changes.
These activities should be incorporated into the project timeline alongside sampling, testing, packaging and manufacturing, with clearly agreed responsibilities and deadlines.
Dasais Italian Cosmetic Hub integrates product development, manufacturing and packaging into a dedicated project process. The scope of specific regulatory services is defined at the beginning of the collaboration.
Discover the Dasais partnership model and explore the complete process in our guide Contract Cosmetic Manufacturing: What It Is, How It Works and How to Choose the Right Manufacturer.
Frequently asked questions
Do I need to resubmit the CPNP if I change the formulation?
The information notified must be updated whenever it changes. In the event of a reformulation, you must assess whether to update the existing notification or submit a new one, whilst also checking the implications for the product documentation.
Is there a fee for CPNP notification?
The European Commission’s portal is free of charge. However, there may be costs associated with preparing the documentation, conducting safety assessments and obtaining professional assistance with data submission and management.
Can I sell a cosmetic product before submitting the notification?
No. The notification must be submitted before the product is placed on the market. The product must also comply with all other requirements applicable to its marketing.

